Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 19, Issue 3, 2001, Pages 321-324

  Lee, S S ^a   Joo, Y S ^a   Kim, W U ^a   Min, D J ^a   Min, J K ^a   Park, S H ^a   Cho, C S ^a   Kim, H Y ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PATIENT; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; JOINTS; LYMPHOKINES; MALE; MIDDLE AGED; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034988575     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. How is blood vessel growth regulated in normal and neoplastic tissue?
2. Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications
3. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation
4. Angiogenesis: A critical process in the pathogenesis of RA - A role for VEGF?
5. Angiogenesis inhibition suppresses collagen arthritis
6. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol
7. Angiogenesis: Implications for rheumatoid arthritis
8. Vascular development and disorders: Molecular analysis and pathogenic insights
9. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis
10. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
11. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1 beta
12. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
13. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis
14. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
15. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
16. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
17. The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales
18. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
19. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
20. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
21. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
22. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
23. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
24. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators
25. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis
26. Vascular endothelial growth factor in patients with rheumatoid arthritis